{"id":21449,"date":"2023-06-27T08:06:47","date_gmt":"2023-06-27T12:06:47","guid":{"rendered":"https:\/\/medicarereport.org\/?p=21449"},"modified":"2023-06-27T08:06:48","modified_gmt":"2023-06-27T12:06:48","slug":"the-dea-relaxed-online-prescribing-rules-during-covid-now-it-wants-to-rein-them-in","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=21449","title":{"rendered":"The DEA Relaxed Online Prescribing Rules During Covid. Now It Wants to Rein Them In."},"content":{"rendered":"\n

(By Arielle Zionts for KFF Health News)<\/p>\n\n\n\n

Federal regulators want most patients to see a health care provider in person before receiving prescriptions for potentially addictive medicines through telehealth \u2014 something that hasn\u2019t been required in more than three years.<\/p>\n\n\n\n

During the covid-19 public health emergency, the Drug Enforcement Administration allowed doctors and other health care providers to prescribe controlled medicine during telehealth appointments without examining the patient in person. The emergency declaration ended May 13, and in February, the agency proposed new rules that would require providers to see patients at least once in person before prescribing many of those drugs during telehealth visits. Continue reading here…<\/a><\/p>\n\n\n\n

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF \u2014 the independent source for health policy research, polling, and journalism<\/p>\n\n\n\n

\"\"<\/p>\n\n\n\n

Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"

(By Arielle Zionts for KFF Health News) Federal regulators want most patients to see a health care provider in person<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[52,15,33],"tags":[730,75,728,727,103],"class_list":["post-21449","post","type-post","status-publish","format-standard","hentry","category-pandemic","category-part-dprescription-drugs","category-telehealth","tag-controlled-medicine","tag-covid-19","tag-covid-19-public-health-emergency","tag-dea","tag-telehealth"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21449"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21449\/revisions"}],"predecessor-version":[{"id":21450,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21449\/revisions\/21450"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}